UCSF

2020 News

Guglielmo receives flu shot
The School continues its vital work in research, education, and patient care.
Arkin
Arkin’s appointment to bolster collaborations between academia and industry for drug discovery.
Spike protein
Team efforts at the School and beyond produce two potential treatments for COVID-19.
Drug resistant bacteria
“Molecular building blocks” give antibiotics an edge over drug-resistant bacteria.
Guglielmo holds the official proclamation of Pharmacist Day in San Francisco while surrounded by PharmD students.
It’s flu shot season and UCSF doctor of pharmacy (PharmD) students once again made sure that School of Pharmacy Dean B. Joseph Guglielmo, PharmD, received his. In what has become an annual tradition, the student-run, interprofessional UCSF Flu Crew gave Guglielmo a quick jab in the arm at the Walgreens pharmacy at the Parnassus Campus and sent him on his way.
Tan gives a video tutorial
Sixteen School of Pharmacy staff members were recognized for their ongoing work supporting the PharmD program
Fujimori
Danica Galonić Fujimori, PhD, will receive $1.25 million in funding over the next five years from the endowment of the late William K. Bowes, Jr., a venture capitalist and longtime UCSF supporter.
Guglielmo.
With the COVID-19 pandemic precluding in-person events, the ceremony took place remotely.
Guglielmo
Dean Guglielmo provides updates on ongoing efforts with science, education, and patient care in the School.
Aerosol spray
School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.
Various pills
School scientists identify excipients with potential to cause side effects
Coronavirus and human cells
UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery
Guglielmo
Our COVID-19 response: A commitment to anti-racist action
Guglielmo and Youmans
We can fully accept that each of us must be part of the solution—and act.
Krogan, Galonic Fujimori, Jura, Fraser, and Agard
The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.
Guglielmo
Our COVID-19 response: As we return to campus, everyone’s well-being is our top concern. But we also need to consider the need to maintain and strengthen community.
Knoben
James Knoben, PharmD ’71, MPH, was named the 2020 UCSF Pharmacy Alumni Association Distinguished Alumnus of the Year.
Human cells infected with SARS-CoV-2 virus
The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.
Guglielmo
Our COVID-19 response: Dean Guglielmo provides an update on School activities and a careful return to campus
Guglielmo
Our COVID-19 response: How COVID-19 is affecting us and where to find updates.
Fraser
Jaime Fraser delivered the 2020 Byers Award Lecture in Basic Science
Guglielmo
Our COVID-19 response: We are rising to the challenges presented by COVID-19.
Ahituv and Inoue
School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.
SARS-COV2 virus particles on human cells
The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.
Guglielmo
Our COVID-19 response: How COVID-19 is affecting us and where to find updates.
Krogan and Fabius
The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.
Koda-Kimble
The award funds the boldest, riskiest, and most blue-sky ideas.
Students in front of a pillar with a "UCSF" banner
The new ranking comes on the heels of the School's recent update to its PharmD curriculum.
Guglielmo
Free samples of medications and “detailing visits” are costly, B. Joseph Guglielmo argues in JAMA.
Giacomini
UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.
The Daniels'
A gift to the UCSF Foundation by Troy Daniels, DDS, and Leslie Daniels, established the endowed Elizabeth Daniels Fund.